⌘K

Login Start Free

Home/Filings/4/0001855763-22-000016

4//SEC Filing

REESE ALBERT L JR 4

Accession 0001855763-22-000016

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 5:25 PM ET

Size

8.0 KB

Accession

0001855763-22-000016

Insider Transaction Report

Form 4

Period: 2022-10-12

Lexaria Bioscience Corp.LEXX

REESE ALBERT L JR

Director

Transactions

Award
Stock Options
2022-10-12+3,200→ 10,000 total
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (3,200 underlying)

Holdings

common shares
10,917
Stock Options
Exercise: $4.80From: 2021-02-01Exp: 2026-02-01→ Common Shares (3,400 underlying)
3,400
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying)
6,800

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001244736

Filing Metadata

Form type: 4
Filed: Oct 12, 8:00 PM ET
Accepted: Oct 13, 5:25 PM ET
Size: 8.0 KB

View on SEC.gov